Joseph S Rosenblatt Deceased719 17Th St, Fort Lauderdale, FL 33304

Joseph Rosenblatt Phones & Addresses

719 17Th St, Fort Lauderdale, FL 33304

Ft Lauderdale, FL

7320 Lake Circle Dr, Pompano Beach, FL 33063

Margate, FL

New York, NY

Valencia, CA

Work

Company: Sylvester Comprehensive Cancer Address: 1475 Nw 12Th Ave, Miami, FL 33136 Phones: (305) 243-1000 (Phone)

Education

School / High School: David Geffen School Of Medicine At UCLA, University Of California, Los Angeles 1980

Languages

English • Spanish

Awards

Healthgrades Honor Roll

Ranks

Certificate: Hematology, 1990

Mentions for Joseph S Rosenblatt

Career records & work history

Medicine Doctors

Joseph Rosenblatt Photo 1

Dr. Joseph D Rosenblatt, Miami FL - MD (Doctor of Medicine)

Specialties:
Hematology
Medical Oncology
Oncology
Address:
Sylvester Comprehensive Cancer
1475 Nw 12Th Ave, Miami, FL 33136
(305) 243-1000 (Phone)
Certifications:
Hematology, 1990
Internal Medicine, 1983
Medical Oncology, 1985
Physical Medicine & Rehabilitation
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Hospitals:
Sylvester Comprehensive Cancer
1475 Nw 12Th Ave, Miami, FL 33136
Mercy Hospital
3663 South Miami Avenue, Miami, FL 33133
Sylvester Comprehensive Cancer Center/UMHC
1475 North West 12Th Avenue, Miami, FL 33136
University of Miami Hospital
1400 North West 12Th Avenue, Miami, FL 33136
Education:
Medical School
David Geffen School Of Medicine At UCLA, University Of California, Los Angeles
Graduated: 1980
Medical School
University Of California-Los Angeles
Graduated: 1980
Medical School
UCLA Affil Hosps
Graduated: 1980
Medical School
UCLA Med Center
Graduated: 1980

Joseph A. Rosenblatt

Specialties:
Endocrinology, Diabetes & Metabolism, Diabetes
Work:
Grove Hill Medical Center Internal MedicineStarling Physicians
300 Kensington Ave STE 1, New Britain, CT 06051
(860) 832-8150 (phone) (860) 224-6953 (fax)
Site
Center For Metabolism Health
100 Grand St FL 3, New Britain, CT 06052
(860) 224-5672 (phone) (860) 224-5956 (fax)
The Center For Metabolism Health
11 South Rd STE 130, Farmington, CT 06032
(860) 224-5433 (phone) (860) 224-5931 (fax)
Education:
Medical School
University of Connecticut School of Medicine
Graduated: 1977
Procedures:
Electrocardiogram (EKG or ECG), Vaccine Administration
Conditions:
Disorders of Lipoid Metabolism, Abnormal Vaginal Bleeding, Acute Bronchitis, Acute Pancreatitis, Acute Pharyngitis, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Alzheimer's Disease, Anemia, Anxiety Phobic Disorders, Atrial Fibrillation and Atrial Flutter, Benign Paroxysmal Positional Vertigo, Benign Thyroid Diseases, Bipolar Disorder, Bronchial Asthma, Calculus of the Urinary System, Cardiac Arrhythmia, Cardiomyopathy, Cataract, Chronic Bronchitis, Chronic Renal Disease, Cirrhosis, Contact Dermatitis, Diabetes Mellitus (DM), Diabetic Peripheral Neuropathy, Diabetic Retinopathy, Erectile Dysfunction (ED), Gastroesophageal Reflux Disease (GERD), Gout, Heart Failure, Hypertension (HTN), Hyperthyroidism, Hypoparathyroidism, Hypothyroidism, Infectious Liver Disease, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Ischemic Heart Disease, Menopausal and Postmenopausal Disorders, Metabolic Syndrome, Multiple Sclerosis (MS), Non-Toxic Goiter, Obstructive Sleep Apnea, Osteoporosis, Overweight and Obesity, Peripheral Nerve Disorders, Polycystic Ovarian Syndrome (PCOS), Prostatitis, Skin and Subcutaneous Infections, Substance Abuse and/or Dependency, Thyroid Cancer, Thyroiditis, Urinary Incontinence, Varicose Veins, Venous Embolism and Thrombosis, Vitamin B12 Deficiency Anemia, Vitamin D Deficiency
Languages:
English, Italian
Description:
Dr. Rosenblatt graduated from the University of Connecticut School of Medicine in 1977. He works in New Britain, CT and 2 other locations and specializes in Endocrinology, Diabetes & Metabolism and Diabetes. Dr. Rosenblatt is affiliated with Hartford Hospital and Hospital Of Central Connecticut.

Joseph D. Rosenblatt

Specialties:
Hematology/Oncology
Work:
Sylvester Comprehensive Cancer Center Hematology
1475 NW 12 Ave STE 3300, Miami, FL 33136
(305) 243-6102 (phone) (305) 243-9161 (fax)
Education:
Medical School
University of California, Los Angeles David Geffen School of Medicine
Graduated: 1980
Procedures:
Bone Marrow Biopsy, Chemotherapy
Conditions:
Hodgkin's Lymphoma, Leukemia, Non-Hodgkin's Lymphoma, Anemia, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Atrial Fibrillation and Atrial Flutter, Candidiasis, Constipation, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Gastroesophageal Reflux Disease (GERD), Heart Failure, Hemolytic Anemia, Herpes Simplex, HIV Infection, Infectious Liver Disease, Malignant Neoplasm of Female Breast, Menopausal and Postmenopausal Disorders, Multiple Myeloma, Osteomyelitis, Peripheral Nerve Disorders, Pneumonia, Pulmonary Embolism, Sickle-Cell Disease, Skin and Subcutaneous Infections, Substance Abuse and/or Dependency, Venous Embolism and Thrombosis
Languages:
English
Description:
Dr. Rosenblatt graduated from the University of California, Los Angeles David Geffen School of Medicine in 1980. He works in Miami, FL and specializes in Hematology/Oncology. Dr. Rosenblatt is affiliated with Jackson Memorial Hospital, Sylvester Comprehensive Cancer Center, University Of Miami Hospital and VA Medical Center-Miami.

Joseph M. Rosenblatt

Specialties:
Orthopedic Pediatric Surgery, Orthopaedic Surgery
Work:
St Christophers Orthopedic Center For Children
3601 A St STE 1331, Philadelphia, PA 19134
(215) 427-3131 (phone) (215) 427-3414 (fax)
Education:
Medical School
Philadelphia College of Osteopathic Medicine
Graduated: 2005
Procedures:
Arthrocentesis, Hallux Valgus Repair, Hip/Femur Fractures and Dislocations, Lower Arm/Elbow/Wrist Fractures and Dislocations, Shoulder Surgery, Spinal Fusion, Joint Arthroscopy, Knee Arthroscopy, Lower Leg/Ankle Fractures and Dislocations, Skull/Facial Bone Fractures and Dislocations, Spinal Surgery, Wound Care
Conditions:
Fractures, Dislocations, Derangement, and Sprains, Scoliosis or Kyphoscoliosis, Acute Conjunctivitis, Diabetic Retinopathy, Hallux Valgus, Internal Derangement of Knee, Internal Derangement of Knee Cartilage, Internal Derangement of Knee Ligaments, Intervertebral Disc Degeneration, Lateral Epicondylitis, Osteomyelitis, Plantar Fascitis, Rheumatoid Arthritis, Sciatica
Languages:
English, Spanish
Description:
Dr. Rosenblatt graduated from the Philadelphia College of Osteopathic Medicine in 2005. He works in Philadelphia, PA and specializes in Orthopedic Pediatric Surgery and Orthopaedic Surgery. Dr. Rosenblatt is affiliated with St Christophers Hospital For Children.
Joseph Rosenblatt Photo 2

Joseph Rosenblatt, Miami FL

Work:
Sylvester Comprehensive Cancer
1475 NW 12Th Ave, Miami, FL 33136Jackson Memorial Hospital
1611 NW 12Th Ave, Miami, FL 33136

Publications & IP owners

Us Patents

Allogeneic Cancer Cell-Based Immunotherapy

US Patent:
8475785, Jul 2, 2013
Filed:
Mar 3, 2009
Appl. No.:
12/921151
Inventors:
Eckhard R. Podack - Coconut Grove FL, US
Joseph D. Rosenblatt - Hollywood FL, US
Nozomi Yamazaki - Sapporo, JP
Assignee:
The University of Miami - Miami FL
International Classification:
A61K 39/00
US Classification:
424 9321, 424 937, 4242771
Abstract:
Cell-based immunotherapy (e. g. , immunization or vaccination) may be improved by frequent administration to a human subject of allogeneic cancer cells secreting a modified heat shock protein (e. g. , gp96), depletion of B cells in the subject, or both. Antigen (e. g. , epitope derived from neoantigen or tumor antigen of allogeneic or syngeneic cancer cells) may induce a specific immune response in the subject. For example, the epitope bound in an immunogenic complex with the secreted heat shock protein may be obtained from allogeneic cancer cells coexpressing both secreted gp96 and antigen, or from syngeneic cancer cells of the subject expressing only antigen.

Rapid Production Of Autologous Tumor Vaccines

US Patent:
2004004, Mar 11, 2004
Filed:
Jun 16, 2003
Appl. No.:
10/463319
Inventors:
Yuman Fong - New York NY, US
Howard Federoff - Rochester NY, US
Joseph Rosenblatt - Rochester NY, US
International Classification:
A61K048/00
C12N015/86
C12N015/869
US Classification:
424/093200, 424/085100, 424/085200, 435/456000
Abstract:
An autologous vaccine to tumor cells is produced by transducing the tumor cells with a herpes virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein by the cells. The tumor cells may transduced with the herpes simplex amplicons ex vivo or in vivo. Suitable immunomodulatory proteins include cytokines, for example, interleukins, interferons, and chemokines such as RANTES, intercellular adhesion molecules, for example ICAM-and costimulatory factors such as BThe tumor cells may also be transduced with one or more species of amplicon containing genes for two or more different immunomodulatory proteins.

Rapid Production Of Autologous Tumor Vaccines

US Patent:
2004015, Aug 12, 2004
Filed:
Mar 24, 2003
Appl. No.:
10/470568
Inventors:
Yuman Fong - New York NY, US
Howard Federoff - Rochester NY, US
Joseph Rosenblatt - Rochester NY, US
International Classification:
C12P021/02
C07H021/04
C07K014/52
C12N015/86
US Classification:
435/069500, 435/456000, 435/320100, 435/325000, 530/351000, 536/023500
Abstract:
An analogous vaccine to tumor cells is produced by transducing the tumor cells with a herpes simplex virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein by the cells. The tumor cells may transduced with the herpes simplex amplicons ex vivo or in vivo. Suitable immunomodulatory proteins include cytokines, for example, interleukins, interferons, and chemokines such as RANTES; intercellular adhesion molecules, for example ICAM-1 and costimulatory factors such as B7.1. The tumor cells may also be transduced with one or more species of amplicon containing genes for two or more different immunomodulatory proteins.

Chimeric Molecules And Methods Of Use

US Patent:
2005000, Jan 13, 2005
Filed:
Jun 2, 2004
Appl. No.:
10/858980
Inventors:
Seung-Uon Shin - Miami FL, US
Sherie Morrison - Los Angeles CA, US
Joseph Rosenblatt - Hollywood FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K039/395
A61K039/00
C07K016/44
US Classification:
424178100, 424192100, 530387300
Abstract:
Chimeric molecules comprising endostatin and all or a portion of an Ig (Ig) molecule are used to treat tumors. A chimeric molecule, including endostatin fused to an Ig domain of an anti-HER2/neu antibody exhibited longer serum half-life and stability than native endostatin. I-labeled anti-HER2/neu IgG3-endostatin chimeric molecule and anti-HER2/neu IgG3 preferentially localized to CT26-HER2 tumors. Clearance of anti-HER2/neu IgG3-endostatin was 6 fold faster than that of anti-HER2/neu IgG3 (CLss=0.374 and 0.062 ml/min/kg, respectively), however, the specific tumor radiolocalization indices of anti-HER2/neu IgG3-endostatin were greater than those of anti-HER2/neu IgG3. Anti-HER2/neu IgG3-endostatin inhibited tumor growth more effectively than endostatin alone, anti-HER2/neu IgG3 antibody, or the combination of antibody and endostatin.

Antibody-Immune Cell Ligand Fusion Protein For Cancer Therapy

US Patent:
2007007, Mar 29, 2007
Filed:
Jun 29, 2006
Appl. No.:
11/427628
Inventors:
Seung-Uon Shin - Miami FL, US
Joseph Rosenblatt - Hollywood FL, US
Khaled Tolba - Miami FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 39/395
C07H 21/04
C12P 21/06
C12N 5/06
C07K 16/30
C07K 16/46
US Classification:
424155100, 435069100, 435328000, 435320100, 530388800, 530391100, 536023530
Abstract:
Compositions for treatment of cancer comprising chimeric fusion molecules that bind to an antigen on a pathogenic cell and to an immune cell. The molecules redirect the immune cells to a pathogenic cell. The purified fusion proteins demonstrated ability to bind antigen on the surface of tumor cells and cell surface receptors on immune cells such as NK cells. The chimeric fusion proteins showed increased cytotoxic activity directed against tumor targets.

Antibody- Endostatin Fusion Protein And Its Variants

US Patent:
2011003, Feb 17, 2011
Filed:
Jun 26, 2008
Appl. No.:
12/665007
Inventors:
Seung-Uon Shin - Miami FL, US
Joseph David Rosenblatt - Miami FL, US
Sherie L. Morrison - Los Angeles CA, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 39/395
A61P 35/00
C07K 19/00
C07H 21/04
C12N 5/10
US Classification:
4241341, 5303873, 536 234, 435328
Abstract:
Chimeric molecules comprising endostatin and all or a portion of a tumor antigen specific binding molecule for use in treating tumors. The chimeric molecule, includes endostatin, endostatin mutants and variants and an antibody or aptamer specific for a desired tumor antigen. Methods of treating cancer comprise administering the chimeric fusion molecules.

Heat Shock Protein Gp96 Vaccination And Methods Of Using Same

US Patent:
2011017, Jul 14, 2011
Filed:
Mar 19, 2009
Appl. No.:
12/933567
Inventors:
Eckhard R. Podack - Coconut Grove FL, US
Joseph R. Rosenblatt - Hollywood FL, US
International Classification:
A61K 39/395
C12N 5/10
A61K 39/00
C12N 15/85
A61P 35/00
A61P 37/04
US Classification:
4241331, 435325, 4241731, 4241531, 4242771, 435455
Abstract:
The invention provides a tumor cell genetically modified to express a nucleic acid encoding a secreted form of a heat shock protein (hsp) gp96 polypeptide. The invention also provides a method of stimulating an immune response to a tumor by administering a tumor cell genetically modified to express a nucleic acid encoding a secreted form of a gp96 polypeptide.

Rapid Production Of Autologous Tumor Vaccines

US Patent:
6051428, Apr 18, 2000
Filed:
Jan 20, 1998
Appl. No.:
9/045476
Inventors:
Yuman Fong - New York NY
Howard Federoff - Rochester NY
Joseph D. Rosenblatt - Rochester NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
University of Rochester - Rochester NY
International Classification:
C12N 1563
C12N 1512
C12N 1538
A61K 39245
US Classification:
435456
Abstract:
An autologous vaccine to tumor cells is produced by transducing the tumor cells with a herpes simplex virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein by the cells. The tumor cells may transduced with the herpes simplex amplicons ex vivo or in vivo. Suitable immunomodulatory proteins include cytokines, for example, interleukins, interferons, and chemokines such as RANTES; intercellular adhesion molecules, for example ICAM-1 and costimulatory factors such as B7. 1. The tumor cells may also be transduced with one or more species of amplicon containing genes for two or more different immunomodulatory proteins.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.